Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Aurinia Pharmaceuticals Inc - Common Shares
(NQ:
AUPH
)
9.040
+0.240 (+2.73%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Aurinia Pharmaceuticals Inc - Common Shares
< Previous
1
2
3
4
5
6
Next >
Why Aurinia Pharmaceuticals Stock Is Plunging
July 26, 2022
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares are trading lower Tuesday after the company received a notice regarding the U.S. Patent Office Patent Trial and Appeal Board's decision to institute...
Via
Benzinga
Why Bank Stocks Traded Sharply Higher; Here's 65 Biggest Movers From Friday
July 18, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering...
Via
Benzinga
Analyst Ratings for Aurinia Pharmaceuticals
April 28, 2022
Analysts have provided the following ratings for Aurinia Pharmaceuticals (NASDAQ:AUPH) within the last quarter:
Via
Benzinga
Why Aurinia Pharmaceuticals Tumbled Despite Its 'Aggressive' 2022 Outlook
February 28, 2022
The company expects 150%-200% growth in its key product. But that wasn't enough.
Via
Investor's Business Daily
Earnings Scheduled For February 28, 2022
February 28, 2022
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (...
Via
Benzinga
Expert Ratings For Aurinia Pharmaceuticals
December 10, 2021
Within the last quarter, Aurinia Pharmaceuticals (NASDAQ:AUPH) has observed...
Via
Benzinga
Aurinia Pharmaceuticals Skids With Its Buyout Thesis Hanging By A Thread
July 15, 2022
The company just hired three new executives, likely putting a buyout in the rearview.
Via
Investor's Business Daily
Citigroup, Bank of America And 48 Stocks Moving In Friday's Mid-Day Session
July 15, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) shares jumped 180.9% to $6.19. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday.
Via
Benzinga
The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More
May 30, 2022
Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for...
Via
Benzinga
The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara
May 20, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
PreMarket Prep Stock Of The Day: Good News From Aurinia Pharmaceuticals In A Down Week
May 10, 2022
Rarely mentioned in the recent chaos in the markets is the biotech sector. With a heavy emphasis in 2020 and 2021 on finding cures and treatments for COVID-19, major drug approvals from the FDA have...
Via
Benzinga
Earnings Preview For Aurinia Pharmaceuticals
May 09, 2022
Aurinia Pharmaceuticals (NASDAQ:AUPH) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Cramer Shares His Thoughts On PubMatic, Aurinia Pharmaceuticals And More
April 05, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said although Kulicke and Soffa Industries, Inc.
Via
Benzinga
103 Biggest Movers From Yesterday
May 11, 2022
Gainers
Via
Benzinga
77 Stocks Moving In Tuesday's Mid-Day Session
May 10, 2022
Gainers
Via
Benzinga
What 4 Analyst Ratings Have To Say About Aurinia Pharmaceuticals
March 08, 2022
Over the past 3 months, 4 analysts have published their opinion on Aurinia Pharmaceuticals (NASDAQ:AUPH) stock. These analysts are typically employed by large Wall Street banks...
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
March 08, 2022
Raymond James cut the price target on Ciena Corporation (NYSE: CIEN) from $80 to $75. Ciena shares fell 10.9% to close at $58.76 on Monday. Telsey Advisory Group cut Capri...
Via
Benzinga
67 Biggest Movers From Yesterday
March 01, 2022
Gainers Mullen Automotive, Inc. (NASDAQ: MULN) climbed 145.6% to close at $1.69 on Monday after the company reported progress on solid-state polymer battery pack...
Via
Benzinga
42 Stocks Moving In Monday's Mid-Day Session
February 28, 2022
Gainers Mullen Automotive, Inc. (NASDAQ: MULN) jumped 74.4% to $1.20 after the company reported progress on solid-state polymer battery pack development. Renewable Energy Group...
Via
Benzinga
Stocks Mixed as Investors Weigh Sanctions
February 28, 2022
U.S. markets have cut a great deal of this morning's losses, though the Dow Jones Industrial Average (DJI) is still down
Via
Talk Markets
Why Aurinia Pharmaceuticals Shares Are Falling Today
February 28, 2022
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is trading significantly lower Monday after the company reported declining fourth-quarter financial results on a year-over-year basis....
Via
Benzinga
Mid-Morning Market Update: Markets Open Lower Amid Ongoing Russia-Ukraine Conflict
February 28, 2022
U.S. stocks opened on a downbeat note this morning, amid the ongoing Russia-Ukraine conflict, which has led to increased US sanctions on Russia. Following the market opening...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
December 10, 2021
Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE:
Via
Benzinga
Aurinia's Voclosporin Shows favorable Risk/Benefit Profile Over 3 Years In Lupus Nephritis
December 09, 2021
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has posted topline results from the AURORA 2 continuation study evaluating the long-term safety and tolerability of...
Via
Benzinga
The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO
December 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Committee Votes Against Recommending Approval Of Kidney Disease Drug...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
December 09, 2021
Good morning, trader! It's time to kick off another busy day of trading with the biggest pre-market stock movers for Thursday!
Via
InvestorPlace
61 Biggest Movers From Yesterday
December 03, 2021
Gainers Jowell Global Ltd. (NASDAQ: JWEL) jumped 25.5% to close at $13.36. Jowell Global recently announced a collaboration with Unilever's Uni-Excubator. Information...
Via
Benzinga
Aurinia Pharma Surges Again As Novartis Joins List Of Potential Suitors
December 02, 2021
Aurinia Pharma popped after Novartis said it's focused on bolt-on deals.
Via
Investor's Business Daily
EXPR Stock: 7 Reasons Why Express Investors Are Feeling Giddy Today
December 02, 2021
Investors in Express (EXPR) stock are celebrating on Thursday thanks to the release of the company's Q3 2021 earnings report.
Via
InvestorPlace
BFRI Stock: The News That Has Biofrontera Shares Bounding Higher Today
December 02, 2021
Biofrontera (BFRI) stock is getting a boost on Thursday thanks to an update from the United States Patent and Trademark Office.
Via
InvestorPlace
Topics
Intellectual Property
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.